-
FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions.
-
A unique study pairing the use of a standard SSRI and SAMe against major depression in subjects who had not responded adequately to SSRI monotherapy suggests safety and significant efficacy over a 6-week trial period.
-
Results of this methodologically sound trial strongly suggest that moderate-dose B vitamin therapy has a protective effect against the rapidly progressive brain atrophy commonly seen in elderly people with mild cognitive impairment (MCI). The intervention was safe and effective over a 2-year time frame, and shows promise for slowing the inexorable progression of MCI to frank dementia.
-
Fibromyalgia patients were randomized to a treatment protocol consisting of 12 weeks of tai chi instruction and practice or a control intervention of wellness education and stretching exercises also of 12 weeks duration. The tai chi treatment group demonstrated clinically significant improvements in pain and quality of life compared to the control group and these improvements were maintained at 24-week follow up.
-
-
Low-dose aspirin, given before 17 weeks, significantly decreases the risk of preeclampsia, severe preeclampsia, IUGR, and preterm birth, compared with its effect when given after that time.
-
Recent decades have seen a dramatic expansion in the visibility of ethnic and cultural diversity in the United States.
-
In september 2010, the most recent study of intercessory prayer was published in the Southern Medical Journal. The researchers suggested that the key to prayer's effectiveness was proximity between the person praying and the one prayed for.
-
-
The World Health Organization (WHO) has issued a global alert and response regarding the use of antivirals for pandemic H1N1 flu, reiterating that antivirals should be used to prevent severe illness and death in children and adults.